Editorial
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2013; 19(36): 5947-5952
Published online Sep 28, 2013. doi: 10.3748/wjg.v19.i36.5947
Table 1 Case-controls studies investigating the association of non-steroidal anti-inflammatory drugs, steroids, opioids, calcium channel blockers and perforated diverticular disease
AuthorCountryDrugsPatients (n)Control group (n)OR
Goh et al[20]United KingdomNSAIDs20HC (600), DD (125)2.1 (95%CI: 1.3-3.4) for HC
4.6 (95%CI: 1.7-12.5) for DD
Mpofu et al[25]United KingdomNSAIDs64HC (320)1.8 (95%CI: 0.96-3.4)
Corder et al[26]United KingdomNSAIDs-DD4.8 (95%CI: 1.6-14.8)
Humes et al[27]United KingdomNSAIDs899HC (8980)1.5 (95%CI: 1.01-2.3)
Piekarek et al[28]SwedenNSAIDs54DD (183)3.6 (95%CI: 1.5-8.4)
Mpofu et al[25]United KingdomSteroids64HC (320)31.9 (95%CI: 6.4-159.2)
Corder et al[26]United KingdomSteroids-DD13.2 (95%CI: 1.81-96.5)
Humes et al[27]United KingdomSteroids899HC (8980)2.7 (95%CI: 1.6-4.6)
Piekarek et al[28]SwedenSteroids54DD (183)28.3 (95%CI: 4.8-165.7)
Humes et al[27]United KingdomOpioids899HC (8980)2.2 (95%CI: 1.6-3.0)
Piekarek et al[28]SwedenOpioids54DD (183)4.5 (95%CI: 1.7-12.2)
Morris et al[3]United KingdomCa2+120HC (480)0.4 (95%CI: 0.2-0.9)
Humes et al[27]United KingdomCa2+899HC (8980)0.54 (95%CI: 0.24-1.24)
Piekarek et al[28]SwedenCa2+54DD (183)0.14 (95%CI: 0.02-0.95)